AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST Conference

slugline:

MA-AVEO-ONCOLOGY

source:

businesswire

Logo Source:

http://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=324594&vid=2

Logo URL:

http://www.aveooncology.com [1]

Logo Width:

120

Logo Size:

Thumbnail

Logo Height:

headline_html:

AVEO Oncology to Present at the Deutsche Bank 2012 dbAccess BioFEST
Conference

dateline:

CAMBRIDGE, Mass.

AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Deutsche Bank 2012 dbAccess BioFEST Conference on Monday, December 3, 2012 at 4:35 p.m. (ET) in Boston.

A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives. AVEO’s proprietary Human Response Platform^TM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company’s website at www.aveooncology.com [2].

contact_html:

Investor: AVEO Oncology Monique Allaire, 617-299-5810 or Media: AVEO Oncology Rob Kloppenburg, 617-930-5595

css:

.bwalignc {text-align: center}

Company Mentioned:

AVEO Oncology [3]